Zimmer Biomet Holdings Financial Statements (ZBH)
|
|
|
|
Report date
|
|
|
07.02.2022 |
25.02.2022 |
31.12.2022 |
24.02.2023 |
23.02.2024 |
|
30.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
7 836 |
6 827 |
6 940 |
6 940 |
7 394 |
|
7 596 |
|
Operating Income, bln rub |
|
|
-1 561 |
860.3 |
696.3 |
1 064 |
1 278 |
|
1 376 |
|
EBITDA, bln rub |
? |
|
1 277 |
2 160 |
1 495 |
2 213 |
2 449 |
|
2 510 |
|
Net profit, bln rub |
? |
|
402.0 |
401.6 |
291.2 |
231.4 |
1 024 |
|
1 084 |
|
|
OCF, bln rub |
? |
|
1 499 |
1 499 |
1 356 |
1 285 |
1 582 |
|
1 582 |
|
CAPEX, bln rub |
? |
|
172.0 |
152.0 |
187.9 |
187.9 |
689.2 |
|
423.8 |
|
FCF, bln rub |
? |
|
1 327 |
1 347 |
1 168 |
1 097 |
892.4 |
|
1 158 |
|
Dividend payout, bln rub
|
|
|
200.1 |
200.1 |
201.2 |
201.2 |
200.9 |
|
198.2 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
49.8% |
49.8% |
69.1% |
86.9% |
19.6% |
|
18.3% |
|
|
OPEX, bln rub |
|
|
7 056 |
3 862 |
4 224 |
3 728 |
3 276 |
|
4 198 |
|
Cost of production, bln rub |
|
|
2 341 |
1 960 |
2 020 |
2 020 |
2 084 |
|
2 561 |
|
R&D, bln rub |
|
|
497.0 |
435.8 |
406.0 |
406.0 |
458.7 |
|
442.2 |
|
Interest expenses, bln rub |
|
|
208.0 |
208.4 |
164.8 |
164.8 |
201.2 |
|
206.4 |
|
|
Assets, bln rub |
|
|
23 456 |
23 456 |
21 066 |
21 066 |
21 497 |
|
21 720 |
|
Net Assets, bln rub |
? |
|
0.000 |
12 661 |
12 027 |
12 021 |
12 481 |
|
12 375 |
|
Debt, bln rub |
|
|
5 463 |
7 079 |
5 697 |
5 697 |
5 995 |
|
6 573 |
|
Cash, bln rub |
|
|
478.0 |
378.1 |
375.7 |
375.7 |
415.8 |
|
569.0 |
|
Net debt, bln rub |
|
|
4 985 |
6 701 |
5 321 |
5 321 |
5 579 |
|
6 004 |
|
|
Ordinary share price, rub |
|
|
159.9 |
123.2 |
127.5 |
127.5 |
121.7 |
|
108.2 |
|
Number of ordinary shares, mln |
|
|
208.9 |
208.6 |
209.6 |
209.6 |
208.7 |
|
202.3 |
|
|
Market cap, bln rub |
|
|
33 401 |
25 708 |
26 724 |
26 724 |
25 399 |
|
21 893 |
|
EV, bln rub |
? |
|
38 386 |
32 409 |
32 045 |
32 045 |
30 978 |
|
27 896 |
|
Book value, bln rub |
|
|
-15 491 |
-1 792 |
-1 617 |
-1 623 |
-1 194 |
|
-1 203 |
|
|
EPS, rub |
? |
|
1.92 |
1.93 |
1.39 |
1.10 |
4.91 |
|
5.36 |
|
FCF/share, rub |
|
|
6.35 |
6.46 |
5.57 |
5.23 |
4.28 |
|
5.72 |
|
BV/share, rub |
|
|
-74.2 |
-8.59 |
-7.71 |
-7.74 |
-5.72 |
|
-5.95 |
|
|
EBITDA margin, % |
? |
|
16.3% |
31.6% |
21.5% |
31.9% |
33.1% |
|
33.0% |
|
Net margin, % |
? |
|
5.13% |
5.88% |
4.20% |
3.33% |
13.8% |
|
14.3% |
|
FCF yield, % |
? |
|
3.97% |
5.24% |
4.37% |
4.10% |
3.51% |
|
5.29% |
|
ROE, % |
? |
|
|
3.17% |
2.42% |
1.92% |
8.20% |
|
8.76% |
|
ROA, % |
? |
|
1.71% |
1.71% |
1.38% |
1.10% |
4.76% |
|
4.99% |
|
|
P/E |
? |
|
83.1 |
64.0 |
91.8 |
115.5 |
24.8 |
|
20.2 |
|
P/FCF |
|
|
25.2 |
19.1 |
22.9 |
24.4 |
28.5 |
|
18.9 |
|
P/S |
? |
|
4.26 |
3.77 |
3.85 |
3.85 |
3.43 |
|
2.88 |
|
P/BV |
? |
|
-2.16 |
-14.3 |
-16.5 |
-16.5 |
-21.3 |
|
-18.2 |
|
EV/EBITDA |
? |
|
30.1 |
15.0 |
21.4 |
14.5 |
12.6 |
|
11.1 |
|
Debt/EBITDA |
|
|
3.90 |
3.10 |
3.56 |
2.40 |
2.28 |
|
2.39 |
|
|
R&D/CAPEX, % |
|
|
289.0% |
286.7% |
216.1% |
216.1% |
66.6% |
|
104.3% |
|
|
CAPEX/Revenue, % |
|
|
2.19% |
2.23% |
2.71% |
2.71% |
9.32% |
|
5.58% |
|
| Zimmer Biomet Holdings shareholders |
